• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Individual and system influences on waiting time for substance abuse treatment.个体和系统因素对药物滥用治疗等待时间的影响。
J Subst Abuse Treat. 2008 Mar;34(2):192-201. doi: 10.1016/j.jsat.2007.03.005. Epub 2007 May 23.
2
Client and program characteristics associated with wait time to substance abuse treatment entry.与药物滥用治疗进入等待时间相关的客户和项目特征。
Am J Drug Alcohol Abuse. 2013 Jan;39(1):61-8. doi: 10.3109/00952990.2012.694515. Epub 2012 Jul 11.
3
Incentives in a public addiction treatment system: Effects on waiting time and selection.公共成瘾治疗系统中的激励措施:对等待时间和选择的影响。
J Subst Abuse Treat. 2018 Dec;95:1-8. doi: 10.1016/j.jsat.2018.09.002. Epub 2018 Sep 7.
4
Engaging substance abusers after centralized assessment: predictors of treatment entry and dropout.集中评估后促使药物滥用者参与治疗:治疗开始及退出的预测因素
J Psychoactive Drugs. 2002 Jan-Mar;34(1):25-31. doi: 10.1080/02791072.2002.10399933.
5
Relationship between waiting time and retention in treatment amongst substance abusers.药物滥用者的等待时间与治疗留存率之间的关系。
Drug Alcohol Depend. 1990 Nov;26(3):255-64. doi: 10.1016/0376-8716(90)90167-d.
6
A brief telephone intervention targeting treatment engagement from a substance abuse program wait list.
J Behav Health Serv Res. 2002 Aug;29(3):288-303. doi: 10.1007/BF02287369.
7
Prevalence of substance use and mental distress among patients on waiting lists for substance use disorder treatment.物质使用障碍治疗等候名单上患者的物质使用和精神困扰的患病率。
J Psychoactive Drugs. 2013 Jul-Aug;45(3):233-40. doi: 10.1080/02791072.2013.805977.
8
Drug treatment outcomes for persons on waiting lists.等待名单上人员的药物治疗结果。
Am J Drug Alcohol Abuse. 2008;34(5):526-33. doi: 10.1080/00952990802146340.
9
Variation in access to outpatient substance abuse treatment: organizational factors and conceptual issues.
J Subst Abuse. 1996;8(4):403-15. doi: 10.1016/s0899-3289(96)90002-4.
10
Treatment barriers identified by substance abusers assessed at a centralized intake unit.在一个集中收治单元对药物滥用者进行评估时发现的治疗障碍。
J Subst Abuse Treat. 2006 Apr;30(3):227-35. doi: 10.1016/j.jsat.2006.01.002.

引用本文的文献

1
Examining facilitative services for entry into substance use disorder treatment: A cluster analysis of treatment facilities.考察促进物质使用障碍治疗进入的辅助服务:治疗机构的聚类分析。
PLoS One. 2024 May 23;19(5):e0304094. doi: 10.1371/journal.pone.0304094. eCollection 2024.
2
Linkage facilitation services for opioid use disorder: Taxonomy of facilitation practitioners, goals, and activities.阿片类药物使用障碍的联系促进服务:促进者的分类、目标和活动。
J Subst Use Addict Treat. 2024 Feb;157:209217. doi: 10.1016/j.josat.2023.209217. Epub 2023 Nov 20.
3
Population-based examination of substance use disorders and treatment use among US young adults in the National Survey on Drug Use and Health, 2011-2019.基于2011 - 2019年美国国家药物使用和健康调查的美国年轻成年人药物使用障碍及治疗情况的人群研究。
Drug Alcohol Depend Rep. 2023 Aug 1;8:100181. doi: 10.1016/j.dadr.2023.100181. eCollection 2023 Sep.
4
Feasibility, Engagement, and Usability of a Remote, Smartphone-Based Contingency Management Program as a Treatment Add-On for Patients Who Use Methamphetamine: Single-Arm Pilot Study.基于智能手机的远程应急管理计划作为甲基苯丙胺使用者治疗附加手段的可行性、参与度及可用性:单臂试点研究
JMIR Form Res. 2023 Jul 6;7:e47516. doi: 10.2196/47516.
5
Technology-based interventions and trainings to reduce the escalation and impact of alcohol problems.基于技术的干预措施和培训,以减少酒精问题的升级和影响。
J Soc Work Pract Addict. 2017;17(1-2):114-134. doi: 10.1080/1533256X.2017.1304948. Epub 2017 Apr 19.
6
Service supply chains for population health: Overcoming fragmentation of service delivery ecosystems.面向人群健康的服务供应链:克服服务提供生态系统的碎片化问题。
Learn Health Syst. 2019 Feb 5;3(2):e10186. doi: 10.1002/lrh2.10186. eCollection 2019 Apr.
7
A Meta-Analysis of the Efficacy of Case Management for Substance Use Disorders: A Recovery Perspective.物质使用障碍病例管理效果的Meta分析:康复视角
Front Psychiatry. 2019 Apr 16;10:186. doi: 10.3389/fpsyt.2019.00186. eCollection 2019.
8
The Effect of Public Insurance Expansions on Substance Use Disorder Treatment: Evidence from the Affordable Care Act.《平价医疗法案对物质使用障碍治疗的影响》。
J Policy Anal Manage. 2019;38(2):366-93.
9
Key Considerations in Planning for Substance Use Treatment: Estimating Treatment Need and Demand.物质使用治疗规划中的关键考量因素:评估治疗需求与需求情况。
J Stud Alcohol Drugs Suppl. 2019 Jan;Sup 18(18):22-30. doi: 10.15288/jsads.2019.s18.22.
10
Do benefits restrictions limit Medicaid acceptance in addiction treatment? Results from a national study.福利限制是否限制了医疗补助在成瘾治疗中的接受程度?一项全国性研究的结果。
J Subst Abuse Treat. 2018 Apr;87:50-55. doi: 10.1016/j.jsat.2018.01.010. Epub 2018 Feb 3.

本文引用的文献

1
Understanding treatment readiness in recently assessed, pre-treatment substance abusers.了解近期评估的治疗前药物滥用者的治疗准备情况。
Subst Abus. 2007 Mar;28(1):11-23. doi: 10.1300/J465v28n01_03.
2
Waiting Time as a Barrier to Treatment Entry: Perceptions of Substance Users.等待时间作为治疗准入的障碍:物质使用者的看法。
J Drug Issues. 2006 Sep;36(4):831-852. doi: 10.1177/002204260603600404.
3
The Multidimensional Structure of Internal Barriers to Substance Abuse Treatment and Its Invariance Across Gender, Ethnicity, and Age.药物滥用治疗内部障碍的多维结构及其在性别、种族和年龄方面的不变性。
J Drug Issues. 2007;37(2):321-340. doi: 10.1177/002204260703700205.
4
Moderators of delay tolerance in treatment-seeking cocaine users.
Addict Behav. 2007 Feb;32(2):370-6. doi: 10.1016/j.addbeh.2006.03.044. Epub 2006 May 18.
5
Treatment barriers identified by substance abusers assessed at a centralized intake unit.在一个集中收治单元对药物滥用者进行评估时发现的治疗障碍。
J Subst Abuse Treat. 2006 Apr;30(3):227-35. doi: 10.1016/j.jsat.2006.01.002.
6
Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?加利福尼亚治疗结果项目中的成本效益分析:药物滥用治疗能“自给自足”吗?
Health Serv Res. 2006 Feb;41(1):192-213. doi: 10.1111/j.1475-6773.2005.00466.x.
7
A randomized controlled trial of interim methadone maintenance.美沙酮维持治疗中期的一项随机对照试验。
Arch Gen Psychiatry. 2006 Jan;63(1):102-9. doi: 10.1001/archpsyc.63.1.102.
8
Where does the waiting list begin? A short review of the dynamics and organization of modern waiting lists.等候名单从何开始?对现代等候名单的动态和组织的简要回顾。
Soc Sci Med. 2006 Jun;62(12):3157-60. doi: 10.1016/j.socscimed.2005.11.030. Epub 2005 Dec 22.
9
Non-fatal overdose and subsequent drug treatment among injection drug users.注射吸毒者中的非致命性药物过量及后续药物治疗
Drug Alcohol Depend. 2006 Jun 28;83(2):104-10. doi: 10.1016/j.drugalcdep.2005.10.015. Epub 2005 Nov 23.
10
The pattern of intravenous drug use and associated criminal activity in patients on a methadone treatment waiting list.美沙酮治疗等候名单上患者的静脉吸毒模式及相关犯罪活动。
Drug Alcohol Rev. 1998 Jun;17(2):159-66. doi: 10.1080/09595239800186961.

个体和系统因素对药物滥用治疗等待时间的影响。

Individual and system influences on waiting time for substance abuse treatment.

作者信息

Carr Carey J A, Xu Jiangmin, Redko Cristina, Lane D Timothy, Rapp Richard C, Goris John, Carlson Robert G

机构信息

Center for Interventions, Treatment, and Addictions Research, Boonshoft School of Medicine, Wright State University, Dayton, OH 45435, USA.

出版信息

J Subst Abuse Treat. 2008 Mar;34(2):192-201. doi: 10.1016/j.jsat.2007.03.005. Epub 2007 May 23.

DOI:10.1016/j.jsat.2007.03.005
PMID:17512159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2268628/
Abstract

Waiting time is a contemporary reality of many drug abuse treatment programs, resulting in substantial problems for substance users and society. Individual and system factors that influence waiting time are diverse and may vary at different points in the treatment continuum. This study assessed waiting time preceding clinical assessment at a centralized intake unit and during the period after the assessment but before treatment entry. The present study included 577 substance abusers who were enrolled in a large clinical trial of two brief treatment interventions in a midsize metropolitan area in Ohio. Bivariate analyses identified individual and system factors that influenced preassessment and postassessment waiting time, as well as total wait to treatment services. Multivariate analyses demonstrated that longer wait time for an assessment is influenced by being court referred, less belief in having a substance abuse problem, and less desire for change. A shorter wait to actually enter treatment is predicted by having a case manager, being more ready for treatment, and having less severe employment and alcohol problems. The different influences present during the two waiting periods suggest that assessment and treatment programs need to implement system changes and entry enhancement interventions that are specific to the needs of substance abusers at each waiting period.

摘要

等待时间是许多药物滥用治疗项目当前面临的现实情况,给药物使用者和社会带来了诸多重大问题。影响等待时间的个人因素和系统因素多种多样,且在治疗连续过程的不同阶段可能有所不同。本研究评估了在一个集中接收单位进行临床评估之前以及评估之后但在开始治疗之前这段时间的等待时间。本研究纳入了577名药物滥用者,他们参与了俄亥俄州一个中等规模大都市地区两项简短治疗干预措施的大型临床试验。双变量分析确定了影响评估前和评估后等待时间以及等待治疗服务总时长的个人因素和系统因素。多变量分析表明,评估等待时间较长受到法庭转介、对存在药物滥用问题的信念较低以及改变意愿较低的影响。有个案管理员、对治疗准备更充分以及就业和酒精问题不太严重,则预示着实际开始治疗的等待时间较短。两个等待阶段存在的不同影响表明,评估和治疗项目需要实施针对每个等待阶段药物滥用者需求的系统变革和入院强化干预措施。